Biorasi’s Neurology and Regenerative Medicine Center of Excellence has become a leader in this evolving field. Our expert team, combined with Biorasi’s close relationship with sites worldwide and access to diverse and hard-to-find patient populations, allow us to guide neurology, pain, psychiatric, and cell therapy trials to success.
Bringing the patient’s perspective into all phases of development.
Randomization and supply management is critical to any clinical trial. But traditionally, it has put a painful lag on the overall efficiency of the process. What if you could take back control and get things done in a matter of days, instead of weeks?
UBC helps pharmaceutical and biotech manufactures overcome access and adherence challenges by using the right combination of our high-touch services and high-tech solutions. Our patient support programs are powered by UBC Pathways™, our proprietary suite of healthcare analytics and technology solutions.
While regulatory compliance is a major driver for serialization projects, breaches to the Pharmaceutical Supply Chain distribution system are also a concern, as they can pose health risks to patients and financial risks to the supply chain stakeholders. At Bellwyck, our holistic and comprehensive approach to serialization ensures these risks will be mitigated and will maximize your value. We have partnered with industry leader Optel Vision to provide you with a flexible serialization solution that can meet a wide range of requirements.
Our experience with DEA Schedule II-V controlled substances and Class I and II chemicals will ensure your product’s integrity and security remain intact. We will serve as your partner with reliable supply chain solutions that will ensure compliance in this strict regulatory environment.
A specialized partner in Hematology and Oncology clinical development.
The knowledge we’ve gained from handling millions of international clinical supply shipments has helped us to develop an expertly managed service.
The only solution that offers both ride and reimbursement automation within one portal.
A hands-on approach provides significant advantages that can shorten drug development timelines and reduce development risk.
|
|
|
|
|
|
|
|
|